Evans v. Bristol-Myers Squibb Company

Case MDL No. 2734 Document 315 Filed 07/01/20 Page 1 of 2 UNITED STATES JUDICIAL PANEL? 68 J. pyusianoyvts, Chari □□ on □ MULTIDISTRICT LITIGATION, doves oy IN RE: ABILIFY (ARIPIPRAZOLE) PRODUCTS LIABILITY LITIGATION MDL No, 2734 FILED (SEE ATTACHED SCHEDULE) Jul 08 2020 SUSAN Y. SOONG CONDITIONAL TRANSFER ORDER (CTO —31) CLERK, U.S. DISTRICT □□□□ NORTHERN DISTRICT OF CALIF: OAKLAND On October 3, 2016, the Panel transferred 20 civil action(s) to the United States District Court for the Northern District of Florida for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See 232 F.Supp.3d 1342 (J.P.M.L. 2016). Since that time, 69 additional action(s) have been transferred to the Northern District of Florida. With the consent of that court, all such actions have been assigned to the Honorable M. Casey Rodgers.

It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Northern District of Florida and assigned to Judge Rodgers.

Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the Northern District of Florida for the reasons stated in the order of October 3, 2016, and, with the consent of that court, assigned to the Honorable M. Casey Rodgers.

This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Northern District of Florida. The transmittal of this order to said Clerk shall be stayed 7 days from the entry thereof. If any party files a notice of-opposition with the Clerk of the Panel within this 7-day period, the stay will be continued untii further order of the Panel. inasmuch 28 no objection is pending al this time, the stay is lifted.

FOR THE PANEL: CLERK'S OFFICE oe □□ John W, Nichols. * Clerk of the Panel FLAD PN axed Case MDL No. 2734 Document 315 Filed 07/01/20 Page 2 of 2 IN RE: ABILIFY (ARIPIPRAZOLE) PRODUCTS LIABILITY LITIGATION MDL No. 2734 SCHEDULE CTO-31 — TAG-ALONG ACTIONS DIST DIV. C.A.NO. CASE CAPTION CALIFORNIA NORTHERN CAN 4 1802584 Davis et al v. Bristol-Myers Squibb Company et al CAN 4 18-02588 Green et al v. Bristol-Myers Squibb Company et al CAN 4 18--02614 Evans et al v, Bristol-Myers Squibb Company et al CAN 4 18-02620 Adeniran et al v. Bristol-Myers Squibb Company et al CAN 4 18-05114 Booth et al v. Bristol-Myers Squibb Company et al CAN 4 18-05118 Stone et al v. Bristol-Myers Squibb Company et al